Tue 14'th Aug 2018
Biostar Pharmaceuticals Stock Analysis
Technical stock analysis for Tue 14'th Aug 2018
|Shorts||0.38% ( 2018-07-31 )|
Biostar Pharmaceuticals fell by -0.99% in the last day from $2.02 to $2.00 The price has fallen in 6 of the last 10 days , but is still up by 6.95% over the past 2 weeks. Volume fell in the last day along with the stock, which is actually a good sign as volume should follow the stock. In the last day the trading volume fell by -50 016 shares and in total 82 364 shares bought and sold for approximately $164 728.00.
Biostar Pharmaceuticals lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.78% during the next 3 months and, with 90% probability hold a price between $0.96 and $1.94 at the end of this period.
Some negative signals were issued as well, and these may have some influence on the near short-term development. Biostar Pharmaceuticals holds a buysignal from the short-term moving average; at the same time, however, a sales signal from the long-term average. Since the longterm average is above the short-term average there is a general sales signal in the stock. On further gains, the stock will meet resistance from the long-term moving average at $2.11. On a fall, the stock will find some support from the short-term average at $1.92. A break-up through the long-term average will give another buy signal, while a fall below the short-term average will add another sales signal and strengthen the general signal. A sales signal was issued from a pivot top point on Monday August 13, 2018, which indicates further falls until a new bottom pivot has been found. Volume fell along with the price during the last trading day, which is technical positive. One should, however, note that this stock may have low liquidity in periods, which increases the general risk.
Relative Strength Index (RSI)
RSI14 is 67 and the stock is currently not being overbought or oversold
Support & Resistance
Biostar Pharmaceuticals finds support from accumulated volume at $1.95.
This stock may move much during a day (volatility) and with periodic low trading volume this stock is considered to be "high risk". During the last day, the stock moved $0.24 between high and low, or 12.97%. For the last week the stock has had a daily average volatility of 10.78%.
Our recommended stoploss: We hold a sell evaluation for this stock. No stop-loss set.
Very Low Low Medium High Very High
Biostar Pharmaceuticals holds several negative signals and we believe that it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our recommendation for this stock since last evaluation from a Buy Candidate to a Sell Candidate.Click for Top 5 Sell Candidates
|Get a PRO membership|
To Reveal Top 5 Sell Candidates
Follow Auto Portfolios gaining up to 30%.
Disclaimer: There is no guarantee against any loss. Your capital is at risk.
Click to become a PRO member